LGND
Ligand Pharmaceuticals IncorporatedNASDAQHealthcare$199.59+2.01%ClosedMarket Cap: $3.98B
As of 2026-04-06
Insider Statistics (Q2 2026)
Purchases
1
Sales
12
Buy/Sell Ratio
0.08
Total Bought
$0.00
Total Sold
$11.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Thu Apr 02 | Reardon Andrew | officer: CLO & Secretary | Sell | 1,302 | $199.72 | 44,620 |
| Thu Apr 02 | Reardon Andrew | officer: CLO & Secretary | Sell | 1,238 | $200.94 | 43,382 |
| Thu Apr 02 | Reardon Andrew | officer: CLO & Secretary | Sell | 460 | $198.85 | 45,922 |
| Thu Apr 02 | Reardon Andrew | officer: CLO & Secretary | Sell | 5,000 | $52.27 | 49,444 |
| Thu Apr 02 | KOZARICH JOHN W | director | Sell | 159 | $204.26 | 42,253 |
| Thu Apr 02 | KOZARICH JOHN W | director | Sell | 146 | $199.97 | 42,574 |
| Thu Apr 02 | KOZARICH JOHN W | director | Sell | 79 | $202.42 | 42,455 |
| Thu Apr 02 | KOZARICH JOHN W | director | Sell | 43 | $202.91 | 42,412 |
| Thu Apr 02 | KOZARICH JOHN W | director | Sell | 40 | $201.24 | 42,534 |
| Tue Mar 31 | LAMATTINA JOHN L | director | Sell | 2,161 | $200.76 | 30,724 |
| Tue Mar 31 | LAMATTINA JOHN L | director | Sell | 2,161 | $114.15 | 32,885 |
| Fri Mar 27 | Reardon Andrew | officer: CLO & Secretary | Sell | 21,525 | $202.55 | 21,525 |
| Fri Mar 27 | Reardon Andrew | officer: CLO & Secretary | Sell | 4,513 | $0.00 | 41,382 |
| Fri Mar 27 | Espinoza Octavio | officer: Chief Financial Officer | Sell | 23,527 | $202.55 | 23,527 |
| Fri Mar 27 | Espinoza Octavio | officer: Chief Financial Officer | Sell | 4,933 | $0.00 | 37,945 |